FDA Dings Medical Device Trial for Lack of IRB Review and Monitoring
A medical device company had to suspend its ongoing pivotal clinical trial and may lose the data collected in the trial so far because of major violations of Good Clinical Practices (GCP) found during an FDA audit. The Warning Letter issued to the company looks like a lesson in the basics of GCP compliance for … Read more